UC Berkeley biochemist Jennifer Doudna and Director of Berlin's Max Planck Institute of Infection Biology Emmanuelle Charpentier, pioneered this easy, inexpensive method of making precise changes in DNA. CRISPR-Cas9 can disable genes, correct genetic disorders or insert mutated genes into animals to create models of human disease.